Skip to content

Drug interactions

Cladribine + Palifermin

Severity: Moderate

Cladribine and Palifermin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Palifermin stimulates growth of epithelial cells, which may make them more vulnerable to cytotoxic chemotherapy if given close in time. Labeling for palifermin reports worse and longer oral mucositis when it was given within 24 hours of chemotherapy.

What this interaction means in plain words

Cladribine and Palifermin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cladribine belongs to Oncology; Palifermin belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Palifermin-stimulated epithelial proliferation increases sensitivity of mucosal cells to cytotoxic agents.

What to do

Do not give palifermin within 24 hours before, during, or 24 hours after cladribine. Follow the labeled timing and monitor for mucositis.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cladribine and Palifermin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cladribine with Palifermin?

MediHelp rates the interaction as moderate. Cladribine and Palifermin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Palifermin stimulates growth of epithelial cells, which may make them more vulnerable to cytotoxic chemotherapy if given close in time. Labeling for palifermin reports worse and longer oral mucositis when it was given within 24 hours of chemotherapy.

How serious is the interaction between Cladribine and Palifermin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not give palifermin within 24 hours before, during, or 24 hours after cladribine. Follow the labeled timing and monitor for mucositis.

What other medicines interact with Cladribine?

MediHelp also lists interactions of Cladribine with, for example, Adenovirus types 4 and 7 live, Siponimod, Tofacitinib. The full list is on the Cladribine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in